Comments on the new guidelines will be accepted until Sept. 18. “The Biden administration has been very vocal in saying they’re going to be very aggressive in the number of challenges and in trying novel theories of potential harm,” said Lauren Norris Donahue, partner and antitrust attorney in the Chicago office of K&L Gates. “It’s across all industries, but health care has been a focus of the Biden administration for enforcement actions.”
Read more:Congress Members Look To Strengthen Federal Privacy Laws In Medical Data
After a 30-day preliminary assessment, the vast majority of deals examined by the FTC and Department of Justice are authorized. But according to Ms. Donahue, a court injunction can be invoked to prevent two organizations from coming together for antitrust purposes, reported Post Gazette.
A non-binding letter of intent to pursue an affiliation with UPMC, a $26 billion healthcare and insurance behemoth with 95,000 employees, was signed by the board of directors of Washington Health System in June. The deal’s financial specifics were kept confidential.
The two federal agencies share enforcement duties and the draft guidelines are just that — non-legally binding principles used to analyze deals that “reflect some key themes the agencies have highlighted in recent cases and advocacy, including concerns about concentration of markets, serial acquisitions, competition in labor markets and practices by dominant firms that cement their position and harm competition,” according to an advisory from the law firm of Buchanan Ingersoll & Rooney PC.
Source: Post Gazette
Featured News
Apple Opens Early Settlement Discussions With DOJ
Jul 17, 2026 by
CPI
South Korean Steelmaker POSCO Expands Supplier Support Pact With Antitrust Regulator
Jul 16, 2026 by
CPI
FCC’s Carr Criticizes California-Led Bid to Block Paramount-Warner Bros. Discovery Deal
Jul 16, 2026 by
CPI
EU Top Court Upholds Antitrust Powers to Seize Corporate Emails
Jul 16, 2026 by
CPI
Uber Launches $14.8 Billion Bid for Delivery Hero in Landmark Food Delivery Deal
Jul 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Agentic AI & Antitrust
Jul 16, 2026 by
CPI
AI Agents and Collusion: The Two Faces of Agentic AI
Jul 16, 2026 by
Giovanna Massarotto
Agentic AI’s Regulatory Conundrum
Jul 16, 2026 by
Anant Raut
Inter-AI-Agent Competition
Jul 16, 2026 by
Stefan Thomas
Navigating the Increasing Regulatory Scrutiny of AI-Pricing Tools: Competition and Other Emerging Risks
Jul 16, 2026 by
Mark Krotoski & Vinny Sidhu